These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2148622)

  • 41. [Prevention of congenital toxoplasmosis].
    Russo M; Galanti B
    Clin Ter; 1990 Sep; 134(6):383-92. PubMed ID: 2149535
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Congenital toxoplasmosis.
    Ho E
    Nurs Times; 1985 Feb 27-Mar 5; 81(9):46-7. PubMed ID: 3845531
    [No Abstract]   [Full Text] [Related]  

  • 43. [The significance of the results of serological tests carried out during pregnancy for the prevention and diagnosis of congenital toxoplasmosis].
    Lässker G; Degen R; Keller J
    Z Kinderheilkd; 1969; 105(2):132-41. PubMed ID: 5813227
    [No Abstract]   [Full Text] [Related]  

  • 44. [ON THE EPIDEMIOLOGY OF TOXOPLASMOSIS].
    MOHR W; PIEKARSKI G
    Dtsch Med Wochenschr; 1964 Jul; 89():1400-2. PubMed ID: 14160355
    [No Abstract]   [Full Text] [Related]  

  • 45. [Toxoplasmosis in pregnancy. Diagnosis and new therapeutic possibilities].
    Mirlesse V; Jacquemard F; Daffos F
    Presse Med; 1993 Feb; 22(6):258-62. PubMed ID: 8511144
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effects of combined treatment of infantile toxoplasmosis with pyrimethamine (daraprim) and sulfonamides on the blood and bone marrow].
    Weissbach G
    Z Arztl Fortbild (Jena); 1965 Jan; 59(1):10-22. PubMed ID: 5885819
    [No Abstract]   [Full Text] [Related]  

  • 47. [Recent advances in the epidemiology, clinical aspects and therapy of toxoplasmosis].
    Tolentino P
    Recenti Prog Med; 1970 Jul; 49(1):1-16. PubMed ID: 4921268
    [No Abstract]   [Full Text] [Related]  

  • 48. Congenital toxoplasmosis: therapeutic strategies.
    Foulon W
    Arch Pediatr; 2003 Feb; 10 Suppl 1():10-1. PubMed ID: 12802954
    [No Abstract]   [Full Text] [Related]  

  • 49. First case of congenital toxoplasmosis from Nepal.
    Rai SK; Sharma A; Shrestha RK; Pradhan P
    Nepal Med Coll J; 2011 Mar; 13(1):64-6. PubMed ID: 21991707
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Congenital toxoplasmosis following infection occurring late in pregnancy].
    Ben Abdallah R; Siala E; Maatoug R; Souissi O; Aoun K; Bouratbine A
    Arch Pediatr; 2011 Jul; 18(7):758-60. PubMed ID: 21632221
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of congenital toxoplasmosis].
    Couvreur J; Desmonts C
    Zentralbl Gynakol; 1983; 105(17):1108-12. PubMed ID: 6650002
    [No Abstract]   [Full Text] [Related]  

  • 52. Prevention of increasing rates of treatment failure by combining sulfadoxine-pyrimethamine with artesunate or amodiaquine for the sequential treatment of malaria.
    Dorsey G; Vlahos J; Kamya MR; Staedke SG; Rosenthal PJ
    J Infect Dis; 2003 Oct; 188(8):1231-8. PubMed ID: 14551894
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Treatment of recurrent congenital ocular toxoplasmosis. Our initial experience with Fansidar].
    Comte P; Verin P; Le Bras M
    Bull Soc Ophtalmol Fr; 1989 Apr; 89(4):567-8, 571-2. PubMed ID: 2686844
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fetal therapy of severe symptomatic toxoplasmosis using azithromycin.
    Tamaru S; Kikuchi A; Takagi K; Wakamatsu M; Horikoshi T; Ogiso Y
    J Obstet Gynaecol Res; 2011 Jul; 37(7):953-7. PubMed ID: 21450026
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic efficacy of quinine plus sulfadoxine-pyremethamine for the treatment of uncomplicated falciparum malaria in Bangladesh.
    Thriemer K; Haque R; Wagatsuma Y; Salam MA; Akther S; Attlmayr B; Fukuda M; Schaecher K; Miller RS; Noedl H
    Am J Trop Med Hyg; 2006 Oct; 75(4):645-9. PubMed ID: 17038687
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria.
    Barnes KI; Little F; Mabuza A; Mngomezulu N; Govere J; Durrheim D; Roper C; Watkins B; White NJ
    J Infect Dis; 2008 Jun; 197(11):1605-13. PubMed ID: 18471066
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Toxoplasmosis and pregnancy].
    Kräubig H
    Med Klin; 1976 Apr; 71(15):603-8. PubMed ID: 772397
    [No Abstract]   [Full Text] [Related]  

  • 58. [Congenital toxoplasmosis diagnosis, a cooperative effort of obstetrician and pediatrician].
    Fanghänel M; Meyfarth G; Molkentin K
    Zentralbl Gynakol; 1969 Jan; 91(1):22-31. PubMed ID: 5385230
    [No Abstract]   [Full Text] [Related]  

  • 59. Mefloquine sulfadoxine pyrimethamine (MSP) combination delays in vitro emergence of mefloquine resistance in multiple drug resistant Plasmodium falciparum.
    Brockelman CR; Thanomsub B; Bhisutthibhand J
    Southeast Asian J Trop Med Public Health; 1989 Sep; 20(3):371-8. PubMed ID: 2699083
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Toxoplasmosis and pregnancy. Prevention, early detection and therapy].
    Thalhammer O
    Zentralbl Gynakol; 1983; 105(16):1086-92. PubMed ID: 6637245
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.